4.0
14 Oct 2024
Recommend
CEO approval
Business outlook
Pros
-Namocell part of Bio-Techne, now backed by big brand -Great people in the company -Cool product -Decent work/life balance
Cons
-Product is new to the market and hard to sell. Capital equipment is a tough sell in this economy in general, and especially in flow cytometry space with several competitors. -Not enough help from Marketing -Frequent issues with instrument in demos + managing customer expectations